Azathioprine for treatment of immune-mediated thrombocytopenia in two horses.

The research paper talks about the use of Azathioprine, an anti-inflammatory drug, as a treatment for immune-mediated thrombocytopenia, a disease causing low blood platelet count, in two horses. The treatment was successful in improving platelet count in both horses.

Introduction to the Topic

• The research looks into the potential of Azathioprine, a medication known to help in the treatment of a specific ailment in humans and dogs, for treating the same disease in horses.
• The disease in question is immune-mediated thrombocytopenia. This is a condition where the immune system works against the body and destroys platelets, which are blood cells necessary for proper blood clotting.
• The two test subjects of the research were two horses that did not respond to conventional corticosteroid therapy for this disease.

Treatment and Response

• Upon administration of the drug Azathioprine, both horses showed improved numbers in platelet counts to acceptable levels.
• The treatment can potentially be regarded as successful since one of the horses was able to return to its racing career. This means that the horse was able to achieve normal function in terms of fitness and activity, signifying a positive response to the drug.
• However, the other horse developed kidney disease and mild laminitis, a hoof disease. These effects were not directly attributed to the effect of Azathioprine, but sadly the horse was euthanized due to these complications.

Implications of the Research

• This small-scale study suggests that Azathioprine may be an effective treatment for horses with immune-mediated thrombocytopenia, especially when they do not present positive responses to corticosteroids.
• This research could pave the way for larger, more extensive studies which could be focused on studying the effect of Azathioprine, not only on platelet counts but also on any potential related or unrelated side effects.